Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Nature Communications
|
February 24, 2011
Rationally tuned micropores within enantiopure metal-organic frameworks for highly selective separation of acetylene and ethylene
Sheng-Chang Xiang, Zhangjing Zhang, Cong-Gui Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 26, 2026
Oligo(ethylene glycol)-functionalized polycarbonate lipid nanoparticles for mRNA delivery with attenuated PEG immunogenicity
Dao Thi Hong Le, Chuan Yang, Yue Zhang, et al.
Leukemia
|
December 27, 2022
IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells
Jifeng Yu, Song Li, Dianze Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 2024
Electrifying HCOOH synthesis from CO<sub>2</sub> building blocks over Cu-Bi nanorod arrays
Guiru Zhang, Bing Tan, Dong Hyeon Mok, et al.
Molecules (Basel, Switzerland)
|
September 9, 2022
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A)
Jifeng Yu, Song Li, Dianze Chen, et al.
Frontiers in Oncology
|
October 18, 2023
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling
Song Li, Dianze Chen, Huiqin Guo, et al.
Journal of Hematology & Oncology
|
November 17, 2022
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal
Jifeng Yu, Song Li, Dianze Chen, et al.
Antibody Therapeutics
|
October 17, 2023
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
Song Li, Dianze Chen, Huiqin Guo, et al.
Heliyon
|
November 18, 2024
IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy
Chunmei Yang, Song Li, Dianze Chen, et al.
ACS Applied Materials & Interfaces
|
October 19, 2020
An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance
Ying-Li Luo, Li-Fang Liang, Yun-Jiu Gan, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Nature Communications
|
February 24, 2011
Rationally tuned micropores within enantiopure metal-organic frameworks for highly selective separation of acetylene and ethylene
Sheng-Chang Xiang, Zhangjing Zhang, Cong-Gui Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 26, 2026
Oligo(ethylene glycol)-functionalized polycarbonate lipid nanoparticles for mRNA delivery with attenuated PEG immunogenicity
Dao Thi Hong Le, Chuan Yang, Yue Zhang, et al.
Leukemia
|
December 27, 2022
IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells
Jifeng Yu, Song Li, Dianze Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 2024
Electrifying HCOOH synthesis from CO<sub>2</sub> building blocks over Cu-Bi nanorod arrays
Guiru Zhang, Bing Tan, Dong Hyeon Mok, et al.
Molecules (Basel, Switzerland)
|
September 9, 2022
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A)
Jifeng Yu, Song Li, Dianze Chen, et al.
Frontiers in Oncology
|
October 18, 2023
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling
Song Li, Dianze Chen, Huiqin Guo, et al.
Journal of Hematology & Oncology
|
November 17, 2022
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal
Jifeng Yu, Song Li, Dianze Chen, et al.
Antibody Therapeutics
|
October 17, 2023
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
Song Li, Dianze Chen, Huiqin Guo, et al.
Heliyon
|
November 18, 2024
IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy
Chunmei Yang, Song Li, Dianze Chen, et al.
ACS Applied Materials & Interfaces
|
October 19, 2020
An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance
Ying-Li Luo, Li-Fang Liang, Yun-Jiu Gan, et al.
Page
of 15